Tumoral cells are known to have a higher ascorbic acid uptake than normal cells. Therefore, the aim of this study was to obtain polymeric nanoparticles containing the antitumoral compound trans-dehydrocrotonin (DHC) functionalized with L-ascorbic acid 6-stearate (AAS) to specifically target this system tumoral cells. Nanoparticle suspensions (NP-AAS-DHC) were prepared by the nanoprecipitation method. The systems were characterized for AAS presence by thin-layer chromatography and for drug loading (81-88%) by UV-Vis spectroscopy. To further characterize these systems, in vitro release kinetics, size distribution (100-140 nm) and Zeta potential by photon-correlation spectroscopic method were used. In vitro toxicity against HL60 cells was evaluated by tetrazolium reduction and Trypan blue exclusion assays. Cell death by apoptosis was quantified and characterized by flow cytometry and caspase activity. Zeta potential analyses showed that the system has a negatively charged outer surface and also indicate that AAS is incorporated on the external surface of the nanoparticles. In vitro release kinetics assay showed that DHC loaded in nanoparticles had sustained release behavior. In vitro toxicity assays showed that NP-AAS-DHC suspension was more effective as an antitumoral than free DHC or NP-DHC and increased apoptosis induction by receptor-mediated pathway. © 2009 Wiley-Liss, Inc. and the American Pharmacists Association.981247964807Ziegler, D.S., Kung, A.L., Therapeutic targeting of apoptosis pathways in cancer (2008) Curr Opin Oncol, 20, pp. 97-103http://www.who.int, last access: 20/02/2008Sofou, S., Surface-active liposomes for targeted cancer therapy (2007) Nanomedicine, 2 (5), pp. 711-724. , http://www.futuremedicine.com/doi/pdf/10.2217/17435889.2.5.711, DOI 10.2217/17435889.2.5.711Castro, M.A., Pozo, M., Cortes, C., Garcia, M.D.L.A., Concha, I.I., Nualart, F., Intracellular ascorbic acid inhibits transport of glucose by neurons, but not by astrocytes (2007) Journal of Neurochemistry, 102 (3), pp. 773-782. , DOI 10.1111/j.1471-4159.2007.04631.xSavona, M., Talpaz, M., Getting to the stem of chronic myeloid leukaemia (2008) Nature Reviews Cancer, 8 (5), pp. 341-350. , DOI 10.1038/nrc2368, PII NRC2368McNulty, A.L., Stabler, T.V., Vail, T.P., McDaniel, G.E., Kraus, V.B., Dehydroascorbate transport in human chondrocytes in regulated by hypoxia and is a physiologically relevant source of ascorbic acid in the joint (2005) Arthritis Rheum, 52, pp. 2676-2685Agus, D.B., Vera, J.C., Golde, D.W., Stromal cell oxidation: A mechanism by which tumors obtain vitamin C (1999) Cancer Res, 18, pp. 4555-4558Marcato, P.D., Durán, N., New aspects of nanopharmaceutical delivery systems (2008) J Nanosci Nanotechnol, 8, pp. 1-4Duran, N., Marcato, P.D., Buffo, C.M.S., De Azevedo, M.M.M., Esposito, E., Poly(epsilon-caprolactone)/propolis extract: Microencapsulation and antibacterial activity evaluation (2007) Pharmazie, 62 (4), pp. 287-290. , DOI 10.1691/ph.2007.4.6058Lee, A.L., Wang, Y., Ye, W.H., Yoon, H.S., Chan, S.Y., Yang, Y.Y., Efficient intracellular delivery of functional proteins using cationic polymer core/shell nanoparticles (2008) Biomaterials, 29, pp. 224-232Jain, K.K., Recent advances in nanoocology (2008) Technol Cancer Res Treat, 7, pp. 1-13Har-El, Y.-E., Kato, Y., Intracellular delivery of nanocarriers for cancer therapy (2007) Current Nanoscience, 3 (4), pp. 329-338. , http://www.ingentaconnect.com/content/ben/cnano/2007/00000003/00000004/ art00005, DOI 10.2174/157341307782418612Arruebo, M., Fernández-Pacheco, R., Ibarra, M.R., Santamaría, J., Magnetic naoparticles for drug delivery (2007) Nanotoday, 2, pp. 22-32Durán, J.D.G., Arias, J.L., Gallardo, V., Delgado, A.V., Magnetic colloids as drug vehicles (2008) J Pharm Sci, 97, pp. 2948-2983Duran, N., Marcato, P.D., De Souza, G.I.H., Alves, O.L., Esposito, E., Antibacterial effect of silver nanoparticles produced by fungal process on textile fabrics and their effluent treatment (2007) Journal of Biomedical Nanotechnology, 3 (2), pp. 203-208. , DOI 10.1166/jbn.2007.022Nair, L.S., Laurencin, C.T., Biodegradable polymers as biomaterials (2007) Progr Polym Sci, 32, pp. 762-798Grynberg, N.F., Echevarria, A., Lima, J.E., Pamplona, S.S.R., Pinto, A.C., Maciel, M.A.M., Anti-tumor activity of two 19-nor-clerodane diterpenes, transdehydrocrotonin and trans-crotonin, from Croton cajucara (1999) Planta Med, 65, pp. 687-689Melo, P.S., Justo, G.Z., Duran, N., Haun, M., Natural killer cell activity and anti-tumour effects of dehydrocrotonin and its synthetic derivatives (2004) European Journal of Pharmacology, 487 (1-3), pp. 47-54. , DOI 10.1016/j.ejphar.2004.01.027, PII S0014299904000895Rodriguez, J.A., Hiruma-Lima, C.A., Brito, A.R.M.S., Antiulcer activity and subacute toxicity of trans-dehydrocrotonin from Croton cajucara (2004) Hum Exp Toxicol, 23, pp. 455-461Silva, R.M., Oliveira, F.A., Cunha, K.M.A., Maia, J.L., Maciel, M.A.M., Pinto, A.C., Nascimento, N.R.F., Rao, V.S.N., Cardiovascular effects of trans-dehydrocrotonin, a diterpene from Croton cajucara in rats Vasc Pharmacol, 43, pp. 11-18Anazetti, M.C., Melo, P.S., Duran, N., Haun, M., Dehydrocrotonin and its derivative, dimethylamide-crotonin induce apoptosis with lipid peroxidation and activation of caspases-2, -6 and -9 in human leukemic cells HL60 (2004) Toxicology, 203 (1-3), pp. 123-137. , DOI 10.1016/j.tox.2004.06.003, PII S0300483X04003282Souza Brito, A.R.M., Rodriguez, J.A., Hiruma-Lima, C.A., Haun, M., Nunes, D.S., Antiulcerogenic activity of trans-Dehydrocrotonin from Croton cajucara (1998) Planta Medica, 64 (2), pp. 126-129Yan, Y., Bornscheuer, U.T., Schmid, R.D., Lipase-catalyzed synthesis of vitamin C fatty acid esters (1999) Biotechnology Letters, 21 (12), pp. 1051-1054. , DOI 10.1023/A:1005620125533Cui, F., Shi, K., Zhang, L., Tao, A., Kawashima, Y., Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation (2006) Journal of Controlled Release, 114 (2), pp. 242-250. , DOI 10.1016/j.jconrel.2006.05.013, PII S0168365906002355, Third International Nanomedicine and Drug Delivery SymposiumHumeau, C., Girardin, M., Rovel, B., Miclo, A., Enzymatic synthesis of fatty acid ascorbyl esters (1998) Journal of Molecular Catalysis - B Enzymatic, 5 (1-4), pp. 19-23. , DOI 10.1016/S1381-1177(98)00090-3, PII S1381117798000903Gryparis, E.C., Mattheolabakis, G., Bikiaris, D., Avgoustakis, K., Effect of conditions of preparation on the size and encapsulation properties of PLGA-mPEG nanoparticles of cisplatin (2007) Drug Delivery, 14 (6), pp. 371-380. , DOI 10.1080/10717540701202937, PII 781274247Anazetti, M.C., Melo, P.S., Duran, N., Haun, M., Comparative cytotoxicity of dimethylamide-crotonin in the promyelocytic leukemia cell line (HL60) and human peripheral blood mononuclear cells (2003) Toxicology, 188 (2-3), pp. 261-274. , DOI 10.1016/S0300-483X(03)00089-1Freire, A.C.G., Melo, P.S., Aoyama, H., Haun, M., Durán, N., Ferreira, C.V., Cytotoxicity effect of lactone from Croton cajucara on human promyelocytic leukemia cells (2003) Planta Med, 69, pp. 67-69Galvao Freire, A.C., Fernandes De Assis, C., Frick, A.O., Da Silva Melo, P., Haun, M., Aoyama, H., Duran, N., Ferreira, C.V., Influence of protein phosphatase inhibitors on HL60 cells death induction by dehydrocrotonin (2003) Leukemia Research, 27 (9), pp. 823-829. , DOI 10.1016/S0145-2126(03)00013-4Stroh, C., Schulze-Osthoff, K., Death by a thousand cuts: An ever increasing list of caspase substrates (1998) Cell Death and Differentiation, 5 (12), pp. 997-1000Mosqueira, V.C.F., Legrand, P., Pinto-Alphandary, H., Puisieux, F., Barratt, G., Poly(D,L-Lactide) nanocapsules prepared by a solvent displacement process: Influence of the composition on physicochemical and structural properties (2000) Journal of Pharmaceutical Sciences, 89 (5), pp. 614-626. , DOI 10.1002/(SICI)1520-6017(200005)89:5<614::AID-JPS7>3.0.CO;2-7Kubo, I., Asaka, Y., Shibata, K., Insect growth inhibitory nor-diterpenes, cis-dehydrocrotonin and trans-dehydrocrotonin, from Croton cajucara (1991) Phytochemistry, 30, pp. 2545-2546Chen, Q., Espey, M.G., Sun, A.Y., Lee, J.-H., Krishna, M.C., Shacter, E., Choyke, P.L., Levine, M., Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo (2007) Proceedings of the National Academy of Sciences of the United States of America, 104 (21), pp. 8749-8754. , DOI 10.1073/pnas.0702854104Gruss-Fischer, T., Fabian, I., Protection by ascorbic acid from denaturation and release of cytochrome c, alteration of mitochondrial membrane potential and activation of multiple caspase induced by H2O2, in human leukemia cells (2002) Biochem Pharmacol, 63, pp. 1325-1335Fransson, L.A., Mani, K., Novel aspects of vitamin C: How important is glypican-1 recycling? (2007) Trends Mol Med, 13, pp. 143-149Czech Jr., M.P., Lawrence, J.C., Lynn, W.C., Evidence for the involvement of sulfhydryl oxidation in the regulation of fat cell hexose transport by insulin (1974) Proc Natl Acad Sci USA, 71, pp. 4173-4177Sagun, K.C., Cárcamo, J.M., Golde, D.W., Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protections against oxidative injury (2005) FASEB J, 19, pp. 1657-1667Xie, S.-Q., Liu, G.-C., Ma, Y.-F., Cheng, P.-F., Wu, Y.-L., Wang, M.-W., Ji, B.-S., Wang, C.-J., Synergistic antitumor effects of anthracenylmethyl homospermidine and alpha-difluoromethylornithine on promyelocytic leukemia HL60 cells (2008) Toxicology in Vitro, 22 (2), pp. 352-358. , DOI 10.1016/j.tiv.2007.09.017, PII S0887233307002615Dzietko, M., Boos, V., Sifringer, M., Polley, O., Gerstner, B., Genz, K., Endesfelder, S., Felderhoff-Mueser, U., A critical role for Fas/CD-95 dependent signaling pathways in the pathogenesis of hyperoxia-induced brain injury (2008) Ann Neurol, 64, pp. 664-673